ARG < AUS

Facettes :

List of bibliographic references

Number of relevant bibliographic references: 22.
[0-20] [0 - 20][0 - 22][20-21][20-40]

Ident.	Authors (with country if any)	Title
000001 (1999)	M. G. Murer ; R. Raisman-Vozari ; O. Gershanik	Levodopa in Parkinson's disease : Neurotoxicity issue laid to rest?
000127 (2000)	M. G. Murer ; G. Dziewczapolski ; P. Salin ; M. Vila ; K. Y. Tseng ; M. Ruberg ; M. Rubinstein ; M. A. Kelly ; D. K. Grandy ; M. J. Low ; E. Hirsch ; R. Raisman-Vozari ; O. Gershanik	The indirect basal ganglia pathway in dopamine D2 receptor-deficient mice
000405 (2002)	Wakako Maruyama ; Yukihiro Akao ; Maria Chrisina Carrillo ; Ken-Ichi Kitani ; Moussa B. H. Youdium ; Makoto Naoi	Neuroprotection by propargylamines in Parkinson's disease: Suppression of apoptosis and induction of prosurvival genes
000416 (2002)	Aïcha Douhou ; Thomas Debeir ; Mario Gustavo Murer ; Louis Do ; Noëlle Dufour ; Véronique Blanchard ; Saliha Moussaoui ; Georg Andrees Bohme ; Yves Agid ; Rita Raisman-Vozari	Effect of chronic treatment with riluzole on the nigrostriatal dopaminergic system in weaver mutant mice
000679 (2004)	C. Warren Olanow ; Yves Agid ; Yoshi Mizuno ; Alberto Albanese ; U. Bonucelli ; Philip Damier ; Justo De Yebenes ; Oscar Gershanik ; Mark Guttman ; F. Grandas ; Mark Hallett ; Ole Hornykiewicz ; Peter Jenner ; R. Katzenschlager ; William J. Langston ; Peter Lewitt ; Eldad Melamed ; M. A. Mena ; P. P. Michel ; Catherine Mytilineou ; Jose A. Obeso ; Werner Poewe ; Niall Quinn ; R. Raisman-Vozari ; Ali H. Rajput ; Olivier Rascol ; Christina Sampaio ; Fabrizio Stocchi	Levodopa in the treatment of Parkinson's disease: Current controversies
000727 (2004)	Juan E. Ferrario ; Irene R. E. Taravini ; Sophie Mourlevat ; Andrea Stefano ; Marina A. Delfino ; Rita Raisman-Vozari ; M. Gustavo Murer ; Merle Ruberg ; Oscar Gershanik	Differential gene expression induced by chronic levodopa treatment in the striatum of rats with lesions of the nigrostriatal system
000820 (2005)	Irene R. E. Taravini ; Juan E. Ferrario ; Jean Delbe ; Laure Ginestet ; Thomas Debeir ; José Courty ; M. Gustavo Murer ; Oscar S. Gershanik ; Rita Raisman-Vozari	Immunodetection of heparin-binding growth associated molecule (pleiotrophin) in striatal intemeurons
000863 (2006)	Alexandre Castro-Caldas ; Paul Delwaide ; Wolfgang Jost ; Marcelo Merello ; Adrian Williams ; Paolo Lamberti ; Miguel Aguilar ; Susanna Del Signore ; Pierre Cesaro	The parkinson-control study : A 1-year randomized, double- blind trial comparing piribedil (150 mg/day) with bromocriptine (25 mg/day) in early combination with levodopa in parkinson's disease
000E22 (2010)	Carlo Colosimo ; Pablo Martinez-Martin ; Giovanni Fabbrini ; Robert A. Hauser ; Marcelo Merello ; Janis Miyasaki ; Werner Poewe ; Cristina Sampaio ; Olivier Rascol ; Glenn T. Stebbins ; Anette Schrag ; Christopher G. Goetz	Task Force Report on Scales to Assess Dyskinesia in Parkinson's Disease: Critique and Recommendations
000E90 (2010)	Santiago Perez-Lloret ; Olivier Rascol	Dopamine Receptor Agonists for the Treatment of Early or Advanced Parkinson's Disease
000E99 (2011)	E. Mulin ; E. Leone ; K. Dujardin ; M. Delliaux ; A. Leentjens ; F. Nobili ; B. Dessi ; O. Tible ; L. Agüera-Ortiz ; R. S. Osorio ; J. Yessavage ; D. Dachevsky ; F. Rj. Verhey ; A. J. Cruz Jentoft ; O. Blanc ; P. M. Llorca ; P. H. Robert	Diagnostic criteria for apathy in clinical practice
000F93 (2011)	Angelo Antonini ; Pablo Martinez-Martin ; Ray K. Chaudhuri ; Marcelo Merello ; Robert Hauser ; Regina Katzenschlager ; Per Odin ; Mark Stacy ; Fabrizio Stocchi ; Werner Poewe ; Oliver Rascol ; Cristina Sampaio ; Anette Schrag ; Glennt. Stebbins ; Christopher G. Goetz	Wearing-Off Scales in Parkinson's Disease: Critique and Recommendations
001002 (2011)	Santiago Perezlloret ; Gabriela Nano ; Andrea Carrosell ; Elkan Gamzu ; Marcelo Merello	A double-blind, placebo-controlled, randomized, crossover pilot study of the safety and efficacy of multiple doses of intra-oral tropicamide films for the short-term relief of sialorrhea symptoms in Parkinson's disease patients
001031 (2012)	Andrew Lees ; Stanley Fahn ; Karla M. Eggert ; Joseph Jankovic ; Anthony Lang ; Federico Micheli ; M. Maral Mouradian ; Wolfgang H. Oertel ; C. Warren Olanow ; Werner Poewe ; Olivier Rascol ; Eduardo Tolosa ; David Squillacote ; Dinesh Kumar	Perampanel, an AMPA Antagonist, Found to Have No Benefit in Reducing "Off" Time in Parkinson's Disease
001157 (2013)	Santiago Perez-Lloret ; Maria Veronica Rey ; Pietro Lucca Ratti ; Olivier Rascol	Rotigotine transdermal patch for the treatment of Parkinson's Disease
001189 (2013)	Agustín Ibá Ez ; Juan F. Cardona ; Yamil Vidal Dos Santos ; Alejandro Blenkmann ; Pía Aravena ; María Roca ; Esteban Hurtado ; Mirna Nerguizian ; Lucía Amouso ; Gonzalo G Mez-Arévalo ; Anabel Chade ; Alberto Dubrovsky ; Oscar Gershanik ; Silvia Kochen ; Arthur Glenberg ; Facundo Manes ; Tristán Bekinschtein	Motor-language coupling: Direct evidence from early Parkinson's disease and intracranial cortical recordings
001223 (2013)	Vanessa V. Dos Santos ; Ana Lúcia S. Rodrigues ; Thereza C. De Lima ; Susana R. De Barioglio ; Rita Raisman-Vozari ; Rui D. Prediger	Ghrelin as a Neuroprotective and Palliative Agent in Alzheimer's and Parkinson's Disease
001889 (1997)	U. K. Rinne ; F. Bracco ; C. Chouza ; E. Dupont ; O. Gershanik ; J. F. Marti Masso ; J. L. Montastruc ; C. D. Marsden ; A. Dubini ; N. Orlando ; R. Grimaldi	Cabergoline in the treatment of early Parkinson's disease : Results of the first year of treatment in a double-blind comparison of cabergoline and levodopa
001908 (1997)	G. Dziewczapolski ; G. Murer ; Y. Agid ; O. S. Gershanik ; R. Raisman-Vozari	Absence of neurotoxicity of chronic L-DOPA in 6-hydroxydopamine-lesioned rats
001A14 (1998)	U. K. Rinne ; F. Bracco ; C. Chouza ; E. Dupont ; O. Gershanik ; J. F. Marti Masso ; J. L. Montastruc ; C. D. Marsden	Early treatment of Parkinson's Disease with cabergoline delays the onset of motor complications: Results of a double-blind levodopa controlled trial
001A31 (1998)	M. G. Murer ; G. Dziewczapolski ; L. B. Menalled ; M. C. Garcia ; Y. Agid ; O. Gershanik ; R. Raisman-Vozari	Chronic levodopa is not toxic for remaining dopamine neurons, but instead promotes their recovery, in rats with moderate nigrostriatal lesions

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/PascalFrancis/Merge

HfdIndexSelect -h $EXPLOR_AREA/Data/PascalFrancis/Merge/FA14s3.i -k "ARG" 

HfdIndexSelect -h $EXPLOR_AREA/Data/PascalFrancis/Merge/FA14s3.i  \
                -Sk "ARG" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/PascalFrancis/Merge/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonFranceV1
   |flux=    PascalFrancis
   |étape=   Merge
   |type=    indexItem
   |index=    FA14s3.i
   |clé=    ARG
}}

---

This area was generated with Dilib version V0.6.29. Data generation: Wed May 17 19:46:39 2017. Site generation: Mon Mar 4 15:48:15 2024